Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sara Xiaoyin Jiang

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Journal of Neuro-Oncology

English

Related publications

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Journal of Clinical Oncology

English

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Wspolczesna Onkologia

English

Neural Progenitor Cell (NPC) Sparing Radiation Therapy (RT) Plus Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Multiforme (GBM) Associated With Neurocognitive Function but Not Tumor Outcomes: Results of a Prospective Clinical Trial

International Journal of Radiation Oncology Biology Physics

English

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi

Oncology

2019

English

Cytotoxic Chemotherapeutic Management of Newly Diagnosed Glioblastoma Multiforme

Journal of Neuro-Oncology

English

A Phase 1/2 Trial of 5 Fraction Stereotactic Radiosurgery With 5 Mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme: Pattern of Recurrence Analysis

International Journal of Radiation Oncology Biology Physics

English

Phase 1 Lead-In to a Phase 2 Factorial Study of Temozolomide Plus Memantine, Mefloquine, and Metformin as Postradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma

English

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

Journal of Clinical Oncology

English

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

British Journal of Cancer

Cancer Research

Oncology

2009

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sara Xiaoyin Jiang

Phase II Trial of Temozolomide (TMZ) Plus Irinotecan (CPT-11) in Adults With Newly Diagnosed Glioblastoma Multiforme Before Radiotherapy

Related publications

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience

Neural Progenitor Cell (NPC) Sparing Radiation Therapy (RT) Plus Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Multiforme (GBM) Associated With Neurocognitive Function but Not Tumor Outcomes: Results of a Prospective Clinical Trial

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Cytotoxic Chemotherapeutic Management of Newly Diagnosed Glioblastoma Multiforme

A Phase 1/2 Trial of 5 Fraction Stereotactic Radiosurgery With 5 Mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme: Pattern of Recurrence Analysis

Phase 1 Lead-In to a Phase 2 Factorial Study of Temozolomide Plus Memantine, Mefloquine, and Metformin as Postradiation Adjuvant Therapy for Newly Diagnosed Glioblastoma

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme